Perdoceo Education Corporation PRDO inked a definitive agreement to acquire full ownership of the University of St. Augustine for Health Sciences, LLC (USAHS). The acquisition, likely to be valued at $142-$144 million, is set to be completed by December 2024. Founded in 1979, USAHS is one of the nation’s leading universities known for its graduate health sciences degrees in physical therapy, occupational therapy, speech-language therapy, nursing and continuing education programs. The university operates campuses in San Marcos, CA; St. Augustine and Miami, FL; and Austin and Dallas, TX, in addition to offering online programs. USAHS holds accreditation from the Western Association of Schools and Colleges (WASC). This strategic acquisition is expected to support PRDO's further growth and diversification of academic programs, particularly in health sciences. It aligns with current technological advancements like AI. It responds to the increasing demand for health science careers, projected to increase 13% by 2031, according to the U.S. Bureau of Labor Statistics, surpassing average job growth rates across sectors. PRDO affirms its full-year adjusted operating income outlook for fiscal 2024, which is expected to range between $175 million and $190 million. The company anticipates the acquisition will enhance its adjusted operating income starting in 2025, with continued growth expected in 2026. This move supports PRDO's strategy of acquiring quality academic institutions to enhance shareholder value through dividends and share buybacks, reflecting its balanced capital allocation approach. Price Performance Shares of this Zacks Rank #3 (Hold) company have gained 32.4% in the past six months compared with the Zacks Schools industry’s 6.7% growth. The company is benefiting from strong student retention and engagement trends at both academic institutions, Colorado Technical University (CTU) and the American InterContinental University System (AIUS or AIU System). Also, the focus on investments in student resources and technology bodes well. Zacks Investment Research Image Source: Zacks Investment Research As of Mar 31, 2024, total student enrollments were 41,300, up 9.0% year over year. Despite a 22.9% year-over-year decline in AIUS enrollments, student enrollments at CTU rose approximately 28.5% compared with the prior-year quarter’s tally. The upside was primarily driven by a positive timing impact from the academic calendar. The company expects continued enrollment growth throughout 2024, following the normalization of marketing and student enrollment activities since the fourth quarter of 2023. The company sees technology as a key driver and competitive advantage. PRDO remains focused on using technology to evaluate student academic experiences and enhance the efficiency of academic and student support functions. It continues to invest selectively to enhance the learning experience for students. It focuses on improving processes supporting corporate engagement programs and prioritizing investments in staff and technology for program expansion. Key Picks Some better-ranked stocks in the Zacks Consumer Discretionary sector are as follows: PlayAGS, Inc. AGS sports a Zacks Rank #1 (Strong Buy). AGS has a trailing four-quarter earnings surprise of 33.3%, on average. The stock has appreciated 73.6% in the past year. You can see the complete list of today’s Zacks Rank #1 stocks here. The consensus estimate for AGS’s 2024 sales and earnings per share (EPS) suggests growth of 7.7% and 5,200%, respectively, from the year-ago levels. American Public Education, Inc. APEI currently flaunts a Zacks Rank #1. APEI has a trailing four-quarter earnings surprise of 138.2%, on average. The stock has surged 317.2% in the past year. The Zacks Consensus Estimate for APEI’s 2024 sales and EPS indicates an increase of 3.9% and 124.6%, respectively, from year-ago levels. Royal Caribbean Cruises Ltd. RCL currently carries a Zacks Rank #2 (Buy). RCL has a trailing four-quarter earnings surprise of 18.3%, on average. The stock has rallied 73.2% in the past year. The Zacks Consensus Estimate for RCL’s 2024 sales and EPS calls for growth of 16.9% and 64%, respectively, from the year-ago levels. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report American Public Education, Inc. (APEI):Free Stock Analysis Report Royal Caribbean Cruises Ltd. (RCL):Free Stock Analysis Report PlayAGS, Inc. (AGS):Free Stock Analysis Report Perdoceo Education Corporation (PRDO):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Perdoceo (PRDO) Expands into Health Sciences With USAHS Buyout
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...